Gadobutrol is a gadolinium-based MRI contrast agent (GBCA). It received marketing approval in Canada and in the United States. As of 2007, it was the only GBCA approved at 1.0 molar concentrations. Gadobutrol is marketed by Bayer Schering Pharma as Gadovist, and by Bayer HealthCare Pharmaceuticals as Gadavist. (Source: http://en.wikipedia.org/wiki/Gadobutrol).
MedKoo Cat#: 314223
Name: Gadobutrol
CAS#: 138071-82-6
Chemical Formula: C18H31GdN4O9
Exact Mass: 605.1332
Molecular Weight: 604.71
Elemental Analysis: C, 35.75; H, 5.17; Gd, 26.00; N, 9.27; O, 23.81
The following data is based on the product molecular weight 604.71 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
